E29: Refractory and Recurrent Idiopathic Granulomatous Mastitis Treatment: Adaptive, Randomized Clinical Trial

In this episode, Lillian Erdahl, MD, FACS, is joined by Fatemeh Shojaeian, MD, MPH, from the Johns Hopkins University School of Medicine. They discuss Dr Shojaeian’s recent article, “Refractory and Recurrent Idiopathic Granulomatous Mastitis Treatment: Adaptive, Randomized Clinical Trial,” in which the authors found that, for resistant or relapsing patients with idiopathic granulomatous mastitis, combining methotrexate and corticosteroids offers a promising strategy. This integration of disease-modifying antirheumatic drugs with corticosteroids not only reduces the necessity for high steroid doses but also effectively alleviates associated side effects.

Disclosure Information: Drs Erdahl and Shojaeian have nothing to disclose.

To earn 0.25 AMA PRA Category 1 Credits™ for this episode of the JACS Operative Word Podcast, click here to register for the course and complete the evaluation. Listeners can earn CME credit for this podcast for up to 2 years after the original air date.

Shojaeian, Fatemeh MD, MPH; Haghighat, Shahpar MD; Abbasvandi, Fereshteh MD; Houshdar Tehrani, Alireza MD; Najar Najafi, Niki BSc; Zandi, Ashkan PhD; Olfatbakhsh, Asiie MD; Sharifi, Maryam MD; Hashemi, Esmat MD; Nafissi, Nahid MD; Najafi, Safa MD. Refractory and Recurrent Idiopathic Granulomatous Mastitis Treatment: Adaptive, Randomized Clinical Trial. Journal of the American College of Surgeons 238(6):p 1153-1165, June 2024. | DOI: 10.1097/XCS.0000000000001046 

Learn more about the Journal of the American College of Surgeons, a monthly peer-reviewed journal publishing original contributions on all aspects of surgery, including scientific articles, collective reviews, experimental investigations, and more.

#JACSOperativeWord